Ilaris and Liver function test abnormal - a phase IV clinical study of FDA data

Summary:

Liver function test abnormal is reported as a side effect among people who take Ilaris (canakinumab), especially for people who are female, 10-19 old, have been taking the drug for < 1 month also take Zantac, and have Juvenile arthritis.

The phase IV clinical study analyzes which people have Liver function test abnormal when taking Ilaris. It is created by eHealthMe based on reports of 13,051 people who have side effects when taking Ilaris from the FDA, and is updated regularly.

What is Ilaris?

Ilaris has active ingredients of canakinumab. eHealthMe is studying from 13,059 Ilaris users. Check the latest studies of Ilaris.

What is Liver function test abnormal?

Liver function test abnormal is found to be associated with 1,491 drugs and 1,963 conditions by eHealthMe. Check the latest studies of Liver function test abnormal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

13,051 people reported to have side effects when taking Ilaris.
Among them, 13 people (0.1%) have Liver function test abnormal.

Could Ilaris cause Liver function test abnormal?

Among these 13 people:

How long have people been on Ilaris when they have Liver function test abnormal? *

What is the gender of people who have Liver function test abnormal when taking Ilaris? *

female: 76.92 %
male: 23.08 %

What is the age of people who have Liver function test abnormal when taking Ilaris? *

What are other drugs people take besides Ilaris? *

What are other side effects people have besides Liver function test abnormal? *

Fever: 9 people, 69.23%
C-Reactive Protein Increased: 7 people, 53.85%
Serum Ferritin Increased: 6 people, 46.15%
Histiocytosis Haematophagic: 5 people, 38.46%
Rashes (redness): 5 people, 38.46%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 4 people, 30.77%
Thrombocytopenia (decrease of platelets in blood): 4 people, 30.77%
Hepatomegaly (abnormal enlargement of the liver): 4 people, 30.77%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 4 people, 30.77%
Hypotension (abnormally low blood pressure): 4 people, 30.77%

What are the existing conditions these people have? *

Juvenile Arthritis (arthritis-related condition that develops in children or teenagers): 6 people, 46.15%
Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 4 people, 30.77%
Still's Disease Adult Onset (a rare illness that causes high fevers, rash, and joint pain in adult just started): 2 people, 15.38%
Rashes (redness): 2 people, 15.38%
Fever: 2 people, 15.38%
Dyspnea (difficult or laboured breathing): 2 people, 15.38%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 7.69%
Histiocytosis Haematophagic: 1 person, 7.69%
High Blood Pressure: 1 person, 7.69%
Autism (a mental condition, present from early childhood, characterized by difficulty in communicating and forming relationships with other people and in using language and abstract concepts): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Ilaris and have Liver function test abnormal?

- Check whether Liver function test abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ilaris:

Ilaris (13,059 reports)

Browse all side effects of Ilaris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Liver function test abnormal:

Liver function test abnormal (1,491 drugs)

Browse all the conditions that are associated with Liver function test abnormal:

Liver function test abnormal (1,963 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on canakinumab (the active ingredients of Ilaris) and Ilaris (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.